Taisho Pharmaceutical Co., Ltd. [Headquarters: Toshima-ku, Tokyo; President: Shigeru Uehara] (hereinafter referred to as "the Company") will renew and release the "Clinilabo Eyelash Serum," which prioritizes hygiene, from its skincare brand "CLINILABO" on Saturday, August 1, 2026. Amidst rising demand for eyelash serums, we launched "Clinilabo Eyelash Serum 3D edge master" in April 2024. Based on Taisho Pharmaceutical's commitment to quality, it features hygienic individual packaging and a unique cotton swab shape developed to suit the application area. Furthermore, with 31 types of cosmetic ingredients*1 blended to provide firmness and resilience to eyelashes, it has been supported by many customers. As an item used around the eyes, we have pursued quality and ease of use that allows consumers to continue using it for a long time. In this renewal, while maintaining the benefits of hygienic individual packaging for every use, we have reviewed the cotton swab shape, serum impregnation rate, usage method, and package design. Clinilabo Researcher ◇ Renewal Points 【01】Cotton Swab Shape ・The number of "dango" (ball) shapes for applying to eyelashes has been changed from the previous 5 to 4. ・By reducing the number of "dango" and thinning the swab shaft, the cotton thickness has been reviewed. 【02】Serum Impregnation Rate ・The cotton thickness has been reviewed, and the serum impregnation rate has been increased by approximately 30% compared to our previous products. ・Furthermore, it has been improved to be less likely to tangle with eyelash extensions than the previous product. 【03】Usage Method ・The usage frequency has been changed from once a night to twice a day, morning and night. ・We recommend using it in the morning before makeup and at night after your skincare routine. 【04】Package Design ・Based on Clinilabo's brand colors, the product message has been refreshed into a simple and easy-to-understand design. ・To express a sense of science, illustrations of the brand c